#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Orthostatic hypotension Glioblastoma Bile acid synthesis disorder Cardiac sarcoidosis Hereditary motor and sensory neuropathy Immunodeficiency common variable Malignant fibrous histiocytoma Homocystinuria Mantle cell lymphoma stage III Diabetes insipidus Retinopathy proliferative Advanced systemic mastocytosis Infantile apnoea Scedosporium infection Hepatocellular carcinoma More trials…

    Learn about Rare Diseases

    Optic glioma – Diagnostics Osteosarcoma metastatic – Basic Information Factor IX deficiency – Basic Information Biotinidase deficiency – Diagnostics Erdheim-Chester disease – Life with Disease Angiosarcoma recurrent – Life with Disease Glomerulonephritis membranoproliferative Crigler-Najjar syndrome – Life with Disease Langerhans’ cell histiocytosis – Treatment Cytokine release syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Danicamtiv Cefotaxime GRAPHITE Danicopan Mitoxantrone Pentixafor Oxcarbazepine A/(H3N2)-LIKE VIRUS ANTIGEN Sym025 Pariglasgene Brecaparvovec Mebufotenin Proline Lenograstim Remifentanil HLX43 Depemokimab Navitoclax Erythromycin Cdr132L Img-007 More therapies…

    Learn about Your Condition

    Meningioma malignant Osteoarthritis Back pain Childhood asthma Lymphangiosarcoma Cardiac valve disease Exposure via breast milk Diabetic retinopathy Vesicoureteric reflux Placenta praevia Nocturia Anal cancer stage II Frontotemporal dementia Catatonia Rheumatic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Poland +1

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Zilovertamab Vedotin
    Czechia Estonia France Greece Italy Norway +3

  • Study on the Effectiveness and Safety of MC2-25 Cream for Itching in Chronic Kidney Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease-associated pruritus
    Investigated Drugs:
    • Alanyl Glutamine
    Germany Hungary Poland

  • Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abemaciclib
    • Palbociclib
    • Pf-07220060 Monohydrate
    Belgium Bulgaria Czechia Denmark Finland France +10

  • Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Riliprubart
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 … 1,629 1,630 1,631 1,632 1,633 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!